This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second view: Discussing the potential of Pulse field ablation for patients with AFib and the recent results of Boston Scientific's Farapulse system in the Advent trial

Ticker(s): BSX, MDT, JNJ, ABT

Who's the expert?

Institution: Orlando Health Heart and Vascular Institute

  • Cardiologist at Orlando Health Heart and Vascular Institute. He is board certified in clinical cardiac electrophysiology and cardiovascular disease.
  • Currently treats 650 patients with cardiovascular disease and familiar with the results from the LoDoCO2 trial, which evaluated Lodoco (Colchicine) in patients with cardiovascular disease.
  • Clinical research experience in cardiovascular treatment investigations and has served as an assistant professor at the Ivan Pavlov Higher Institute of Medicine and as an instructor at the Albert Einstein College of Medicine.

Interview Goal
afib

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.